Pancreatic cancer vaccine shows promising results
Scientists at Case Western Reserve University have created a new vaccine that's showing real promise against pancreatic ductal adenocarcinoma—the most aggressive type of pancreatic cancer. In early tests, it wiped out tumors in over half of the models studied, using nanoparticles to jumpstart the immune system.
A 3-dose plan to train your immune system
The vaccine uses a simple three-dose plan to train your immune system, aiming for long-lasting protection. It works even better when paired with certain immunotherapy drugs that help unmask hidden tumors. Not only did it attack cancer right away, but it also helped the body remember how to fight off future threats.
Researchers hopeful of human trials
This shot might also help prevent cancer in people who are genetically at risk—not just treat those already sick. With fresh funding from the National Cancer Institute, the team is advancing their research with hopes of eventually progressing to human trials. As one researcher shared, they're hopeful this breakthrough could protect high-risk folks before cancer even starts.